menu close
Access The Private Market

Explore Companies

With a comprehensive suite of private market programming and liquidity solutions, Nasdaq Private Market can help unlock the power of data for market participants worldwide.

A-Alpha Bio

A biotechnology company that accelerates therapeutic discovery by analyzing protein interactions using synthetic biology and machine learning.

Abata Therapeutics

Develops cell therapies using regulatory T cells to treat autoimmune diseases, restore immune balance, and promote tissue repair.

ADARx Pharmaceuticals

Develops RNA-targeting therapeutics.

Adimab

Operates as an antibody discovery company.

Altopharmacy-Logo

Alto Pharmacy

Distributes medication and uses technology to make the pharmacy experience more convenient for patients.

Ampersand Bio

Develops targeted therapeutics using the AND™ Platform to treat diseases precisely, minimizing side effects and toxicities.

Angiex

Develops nuclear-delivered antibody-drug conjugates to target tumor cells and blood vessels, creating innovative cancer treatments.

Anivive

Develops innovative veterinary pharmaceuticals and diagnostics using AI technology to advance pet healthcare solutions for diseases and infections.

Ankyra

Develops anchored immunotherapies that improve drug efficacy.

Apnimed

Develops oral pharmacologic therapies.

Appia Bio

Develops universal cell therapies using engineered iNKT cells from stem cells to create accessible, off-the-shelf treatments.

Arbor Biotechnologies

Develops next-generation gene editing therapies using a diverse toolbox of novel gene editors.

ArriVent Biopharma

Clinical-stage biopharma company develops targeted therapies for difficult-to-treat cancers, advancing novel oncology treatments through trials.

Arsenalbio-Logo

ArsenalBio

Develops programmable cell therapies for cancer patients.

Asher Biotherapeutics

Develops targeted immunotherapies for cancer and diseases using a cis-targeting platform.

Attovia Therapeutics-Logo

Attovia

Pipeline of bio-therapeutics with an initial focus on immune-mediated diseases.

Attralus

Developing transformative medicines to improve the lives of patients with systemic amyloidosis.

Autobahn Therapeutics

Develops targeted therapeutics for neurological diseases using brain-targeting chemistry platform to create regenerative treatments for CNS disorders.